Levosimendan Related Compound F - Request Quote
Levosimendan Related Compound F
| SZ CAT No: | SZ-L078015 |
| CAS No | NA |
| Mol.F. | C14H12N4O3 |
| Mol.Wt. | 284.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Levosimendan Related Compound F is chemically 4-(4-(2-(dicyanomethylene)hydrazinyl)phenyl)-3-methyl-4-oxobutanoic acid. Levosimendan Related Compound F is supplied with detailed characterization data compliant with regulatory guideline. Levosimendan Related Compound F can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Levosimendan.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Levosimendan Related Compound F
Purchase Levosimendan Related Compound F
Levosimendan Related Compound F suppliers
Levosimendan Related Compound F manufacturers
Levosimendan Related Compound F price
Order Levosimendan Related Compound F
Enquire Levosimendan Related Compound F
Levosimendan Related Compound F cost
Levosimendan Related Compound F Supplier
Levosimendan Related Compound F Distributor
Levosimendan Related Compound F for Method Validation
Levosimendan Reference Standard
Levosimendan Related Compound F for ANDA Filing
Levosimendan Related Compound F for Forced Degradation Studies
Levosimendan Related Compound F Identification Standards
Levosimendan Related Compound F for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


